Stock-based compensation increased 121.2%
Stock-based compensation changed +121.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$443,000→$980,0004 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →XGN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income increased 34.5%
Operating income changed +34.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
-$2.6M→-$1.7M4 prior comparisons
Operating margin moved 665 bp higher
Operating margin changed +665 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
-15.29%→-8.64%4 prior comparisons
Revenue increased 15.9%
Revenue changed +15.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$17.2M→$19.9M4 prior comparisons
Net income increased 28.0%
Net income changed +28.0% from the comparable as-filed period.
-$4.4M→-$3.2M3 prior comparisons
SBC / revenue moved 234 bp higher
SBC / revenue changed +234 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
2.58%→4.91%4 prior comparisons
Cash & equivalents decreased 18.1%
Cash & equivalents changed -18.1% from the comparable as-filed period.
$30.0M→$24.6M2 prior comparisons
Gross margin moved 84 bp higher
Gross margin changed +84 basis points from the comparable as-filed period.
60.43%→61.27%3 prior comparisons
Gross profit increased 17.5%
Gross profit changed +17.5% from the comparable as-filed period.
$10.4M→$12.2M3 prior comparisons
Debt decreased 0.6%
Debt changed -0.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$23.0M→$22.8M4 prior comparisons
Research & development decreased 3.8%
Research & development changed -3.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$1.5M→$1.4M4 prior comparisons
Selling, general & administrative increased 8.4%
Selling, general & administrative changed +8.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$11.5M→$12.5M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.